Jazz Pharmaceuticals plc (JAZZ)
NASDAQ: JAZZ · Real-Time Price · USD
136.01
-0.64 (-0.47%)
Feb 21, 2025, 4:00 PM EST - Market closed
Jazz Pharmaceuticals Analyst Ratings
Total Analysts
14
Consensus Rating
Strong Buy
Price Target
$177.50
Upside
+30.51%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Hold → Buy Upgrades $130 → $170 | Hold → Buy | Upgrades | $130 → $170 | +24.99% | Feb 13, 2025 |
| Piper Sandler | Piper Sandler | Buy Reiterates $163 | Buy | Reiterates | $163 | +19.84% | Dec 12, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $179 | Buy | Reiterates | $179 | +31.61% | Dec 12, 2024 |
| Needham | Needham | Strong Buy Reiterates $207 | Strong Buy | Reiterates | $207 | +52.19% | Dec 12, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $179 | Buy | Reiterates | $179 | +31.61% | Dec 10, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $200 | Strong Buy | Reiterates | $200 | +47.05% | Nov 22, 2024 |
| Needham | Needham | Strong Buy Reiterates $207 | Strong Buy | Reiterates | $207 | +52.19% | Nov 21, 2024 |
| Piper Sandler | Piper Sandler | Buy Reiterates $166 → $163 | Buy | Reiterates | $166 → $163 | +19.84% | Nov 21, 2024 |
| Baird | Baird | Buy Maintains $154 → $162 | Buy | Maintains | $154 → $162 | +19.11% | Nov 18, 2024 |
| Needham | Needham | Strong Buy Reiterates $207 | Strong Buy | Reiterates | $207 | +52.19% | Nov 7, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $175 → $179 | Buy | Maintains | $175 → $179 | +31.61% | Oct 23, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $174 → $175 | Buy | Maintains | $174 → $175 | +28.67% | Oct 4, 2024 |
| Needham | Needham | Strong Buy Reiterates $205 | Strong Buy | Reiterates | $205 | +50.72% | Sep 10, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $140 | Buy | Reiterates | $140 | +2.93% | Sep 9, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $190 → $202 | Buy | Maintains | $190 → $202 | +48.52% | Aug 19, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $140 | Buy | Reiterates | $140 | +2.93% | Aug 1, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.